The efficacy of Venlafaxine in comparison with placebo in the treatment of adult with attention deficit hyperactivity disorder: A double blind randomized clinical trial

Trial Profile

The efficacy of Venlafaxine in comparison with placebo in the treatment of adult with attention deficit hyperactivity disorder: A double blind randomized clinical trial

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2013

At a glance

  • Drugs Venlafaxine (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 Jan 2012 Results published in Human Psychopharmacology: Clinical and Experimental.
    • 18 Jan 2012 Status changed from active, no longer recruiting to completed.
    • 07 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top